Soft Tissue Sarcoma Excluding Gist clinical trials

Explore recruiting soft tissue sarcoma excluding gist clinical trials.

Recruiting soft tissue sarcoma excluding gist studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Soft Tissue Sarcoma Excluding Gist trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors

Germany, Portugal, France, Spain, Denmark

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Soft Tissue Sarcoma Excluding Gist trials by city

Soft Tissue Sarcoma Excluding Gist clinical trials

Recruiting soft tissue sarcoma excluding gist studies right now

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall

Also recruiting in Europe

A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors

Soft Tissue Sarcoma Excluding Gist trials by city

Other conditions